Clinical Trials Directory

Trials / Terminated

TerminatedNCT03503097

Genetic Testing for Men With Metastatic Prostate Cancer

GENTleMEN: Genetic Testing for Men With Metastatic Prostate Cancer

Status
Terminated
Phase
Study type
Observational
Enrollment
799 (actual)
Sponsor
University of Washington · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.

Detailed description

OUTLINE: Participants receive web-based or hard-copy questionnaires and saliva collection kits via mail or in person. Participants also provide saliva samples to be mailed back to Color Genomics for genetic testing once complete. Participants then receive phone-based genetic counseling if they are identified to have an inherited mutation in a deoxyribonucleic acid (DNA) repair gene. All participants have access to phone-based genetic counseling whether or not they are not found to have a mutation. After study completion, participants are followed up at 6 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionProvide saliva samples
OTHERGenetic CounselingUndergo counseling
OTHERGenetic TestingUndergo genetic testing
OTHERLaboratory Biomarker AnalysisCorrelative studies
BEHAVIORALQuestionnaireComplete questionnaire

Timeline

Start date
2017-08-21
Primary completion
2024-08-21
Completion
2025-09-17
First posted
2018-04-19
Last updated
2025-10-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03503097. Inclusion in this directory is not an endorsement.